Zafrens uses nanofabrication technology to analyze and manipulate cells for drug discovery, integrating multiple disciplines to advance cellular analysis and drug development.

Zafrens

Zafrens | 2,161 followers on LinkedIn. Opening doors to new insights at the interface of biology, chemistry and engineering | Zafrens is a therapeutics company pioneering an ultra-high throughput platform to isolate, culture, image, and sequence millions of cells per day. The proprietary platform allows for full characterization of diverse cell populations, as well as directly correlating molecular profiles (DNA, RNA, protein) to cell phenotype and function. The company’s mission is to unlock the full story of every cell to accelerate drug discovery.

Drug Hunter and Informatics Expert

Peter Nestler

Venture investor, Harvard professor, entrepreneur

Wasim Malik

Director, Software & Analytics at Zafrens

Steven Brown

Cofounder/Executive Director

Ravi Ramenani

"We think [this approach] to drug discovery and analysis where we miniaturize everything - we do high throughput experiments, but also high resolution experiments - will reveal insights that will allow us to try to democratize and make drug discovery simpler and cheaper" Swamy Vijayan, Founder & CEO Zafrens on Bio_Unlock Episode #002: The Future of Drug Discovery. Watch the full conversation here: https://lnkd.in/dXmDRds6 (or wherever you get your podcasts)

BlueYard Capital

Our CEO, Kandaswamy (Swamy) Vijayan recently joined a podcast Bio_Unlock hosted by BlueYard Capital , alongside Elliot Hershberg , author of the popular newsletter "Century of Biology". Swamy discussed his interdisciplinary approach that merges biology, chemistry, and engineering to understand and manipulate cell states. By miniaturizing experiments and screening at ultra-high throughput, Zafrens is challenging traditional drug discovery methods, enabling the study of thousands of cells simultaneously. Elliot shared insights into the evolution of biotech towards "tech bio," emphasizing the importance of engineering disciplines in revolutionizing biological research. They discussed the transformative potential of AI and machine learning in analyzing vast datasets and guiding experimental design. Thanks to Elliot, Anastasia, and BlueYard Capital for the insightful discussion! 🎙️ #Immunotherapy #Innovation #startup Direct link here: https://lnkd.in/dXmDRds6

We are excited to announce that our CEO Kandaswamy (Swamy) Vijayan will be joining a panel discussion at the Precision Medicine World Conference #PMWC24 next week! Register for the conference here: https://lnkd.in/gM_Xxdi7 Follow our page for future updates at Zafrens Are you interested in learning more about Zafrens or our recently launched Ultra High-Throughput Functional Genomics "Z-Screen" Platform? Leave a message at hello@zafrens.com PMWC - Precision Medicine World Conference , Tal Behar , #PMWC24

Thank you to Genetic Engineering & Biotechnology News (GEN) for speaking with our CEO Swamy Vijayan about Zafrens' $23M financing, as well as our partnering and growth plans! Please reach out to learn more about our exciting work to compress early drug discovery at a fraction of traditional costs by using 200,000 microwell arrays in place of 96 well plates. #drugdiscovery#pharma#biotech#financing#TCR#smallmolecule#bispecific#antibody#biologics#CAR-T#cell#therapy https://lnkd.in/db-Sg5m9

Hello, world! Happy to announce our financing and emergence from stealth. Please reach out if you feel we can work together!

CrUX Dataset

CrUX Top 50m

Co-Founder & EVP of Engineering

Yi Zhang

Engineering

Director, Software & Analytics

Product Development Leader

Chris Kilcoin

Allan Nojadera

Founding Scientist

Devin Porter

EVP, Corporate Development

Glenn Dourado

Senior Scientist-Biology-Technology Integration

Jason Stricker

Chief Executive Officer

Kandaswamy Vijayan

Machine Learning and Software Engineer

Kyle Boland

Justin Briggs

EVP of Engineering

West Coast Companies With Fewer Than 100 Employees (Top 10K)

United States Early Stage Companies With Fewer Than 1000 Employees (Top 10K)

California Life Science Companies

Life Science Startups

Zafrens is a drug discovery company that develops life sciences products that allow full characterization of diverse cell populations. The company's platform specializes in generating insights at the interface of biology, chemistry, and engineering.

The company was founded in 2021 and is headquartered in San Diego, California, United States.

Prime Movers Lab

Series A - Zafrens

Alix Ventures

Seed Round - Zafrens

Pre Seed Round - Zafrens

Computer and Software Services and Scientific Services

San Diego

California

United States

North America

Mitsui Chemicals Invests in Zafrens, a High-Throughput Single-Cell Analysis and Drug Discovery Company

Zafrens Raises $23M in Financing

Zafrens Plans to Advance Multimodal Drug Discovery Platform with $23M Financing

Zafrens Launches with $23M in Financing to Advance Multiple Stages of Drug Discovery in a Single Experiment at Unprecedented Scale

Zafrens Launches with $23M in Financing to Advance Multiple Stages of Drug Discovery in a Single Experiment at ...

Zafrens Closes $23M Financing

Switzerland

Europe

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 6, 2024 11:05 PM	fff8d9dc
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 6, 2024 11:05 PM	98b2e0ae
crunchbase trigger	general	Nov 6, 2024 11:05 PM	fe89ade9
crunchbase profile	general	Nov 7, 2024 6:29 PM	17be4b40
li profile	general	Nov 6, 2024 11:05 PM	79384c50
translate crunchbase fundingrounds	general	Nov 7, 2024 7:12 PM	9089f09a
peers	general	Nov 6, 2024 11:05 PM	4a486a8b
news basic	general	Nov 6, 2024 11:05 PM	4f8a7230
bundesanzeiger	filings
financials download nd	financials
private financials	financials

ZAFR

COM:ZAFRENS

Zafrens